Information about Longitudinal 2 PAMPI Funding
My details
*
*
*
No warnings for this company
{{translate('company_activity_bron_' + bron)}}
Code Description
{{activiteit.code}} {{activiteit.description}}

Longitudinal 2 PAMPI Funding (SRL)

Company information

Status
Active

KVK number

73074969

VAT Number

Established
12-11-2018
Last balance sheet year
2024
Company size
Big 0 FTE
RSIN number
859344381
Principal activity
Activiteiten van financieringsentiteiten binnen concernverband
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Longitudinal 2 PAMPI Funding

2024 2023 2021 2020
Profit/Loss USD 12.787 4 % USD 12.320 - -
Equity USD 74.028 21 % USD 61.241 48 % USD 41.308 86 % USD 22.232
Gross margin USD 12.400.627 -5 % USD 13.069.501 -12 % USD 14.799.967 -5 % USD 15.636.267
Employees 0 0 0 0

Frequently asked questions

What is the VAT number of Longitudinal 2 PAMPI Funding?
Log in or start a free trial to view the VAT number.
What is the KVK number of Longitudinal 2 PAMPI Funding?
The KVK number of Longitudinal 2 PAMPI Funding is 73074969
When was Longitudinal 2 PAMPI Funding founded?
Longitudinal 2 PAMPI Funding was founded on 12-11-2018.
What is the address of Longitudinal 2 PAMPI Funding?
The current registered office of Longitudinal 2 PAMPI Funding is located at Herikerbergweg 88, 1101 CM Amsterdam.
When was the last time Longitudinal 2 PAMPI Funding filed their annual financial statements?
The most recent financial statements of Longitudinal 2 PAMPI Funding were filed on 23-07-2025.
How many employees does Longitudinal 2 PAMPI Funding have?
There are currently no employees working at Longitudinal 2 PAMPI Funding or no workforce information is available.
What is the annual turnover of Longitudinal 2 PAMPI Funding?
There is no turnover available for Longitudinal 2 PAMPI Funding.